[Electrophoresis mobility inhibition test (emt) in immunological early diagnosis of gynaecological malignomas (author's transl)].
The electrophoresis mobility inhibition test (EMT) was employed in the examination of a total of 74 woman patients with various gynaecological malignomas, 50 women with non-malignant diseases and 41 healthy female controls. In the group of patients with  malignoma, 78.4% of the test results agreed with the histological diagnosis, 21.6% of the results were false negative. In the group of patients with benign diseases, 78.0% of the test results were correct, whereas 22.0% were false-positive. One false-positive test result was seen among the healthy controls. Extensive tumour growth, chronic infections and virus diseases seem to falsify the test result. Significance, perspectives and limitations of this test system within the framework of tumour diagnosis, are discussed.
D001424:Bacterial Infections / Q000175:diagnosis; D003937:Diagnosis, Differential; D005189:False Positive Reactions; D005260:Female; D005833:Genital Neoplasms, Female / Q000175:diagnosis* / Q000276:immunology; D006801:Humans; D007122:Immunoelectrophoresis; D007961:Leukocyte Migration-Inhibitory Factors / Q000032:analysis*; D008222:Lymphokines / Q000032:analysis*; D014777:Virus Diseases / Q000175:diagnosis
D007961:Leukocyte Migration-Inhibitory Factors; D008222:Lymphokines
Der Elektrophorese-Mobilitäts-Hemmtest (EMT) zur immunologischen Frühdiagnostik gynäkologischer Malignome.